Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis | Synapse

August 4, 2010

Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

An iron efflux pump is a pivotal protein in breast cancer biology and a strong and independent predictor of breast cancer prognosis.

Preguntar a la IA

Me gusta

Guardar

Compartir

Cite This Study

Pinnix et al. (Wed,) studied this question.

synapsesocial.com/papers/69de9e65499d77a496b0c2eb https://doi.org/https://doi.org/10.1126/scitranslmed.3001127

Preguntar a la IA

Me gusta

Guardar

Compartir

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.1990 · 1,560 citations
2Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.1997 · 187 citations
3Preferential repression of the H subunit of ferritin by adenovirus E1A in NIH-3T3 mouse fibroblasts.1993 · 44 citations
4Coordinated Regulation of Iron-Controlling Genes, H-Ferritin and <i>IRP2</i> , by c-MYC1999 · 325 citations
5Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.2001 · 90 citations